Eventide Asset Management’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History

Eventide Asset Management’s Portfolio FRLN Stock Details FRLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-313,509	Closed	-$2.16M	–	159
2023 Q1	$2.16M	Sell	313,509 -81,209	-21%	-$630K	0.04%	136
2022 Q4	$2.92M	Sell	394,718 -1,949	-0.5%	-$18.6K	0.06%	130
2022 Q3	$4.09M	Hold	396,667	–	–	0.08%	126
2022 Q2	$5.17M	Buy	396,667 +156,254	+65%	+$2.01M	0.11%	118
2022 Q1	$3.97M	Buy	240,413 +8,036	+3%	+$149K	0.06%	127
2021 Q4	$6.75M	Hold	232,377	–	–	0.09%	122
2021 Q3	$11.8M	Buy	232,377 +66,667	+40%	+$4.74M	0.16%	119
2021 Q2	$19.8M	Hold	165,710	–	–	0.27%	95
2021 Q1	$29.8M	Hold	165,710	–	–	0.44%	73
2020 Q4	$44.3M	Buy	165,710 +9,490	+6%	+$2.39M	0.68%	52
2020 Q3	$35.6M	Buy	+156,220	New	+$39.2M	0.7%	48

Other funds holding FRLN

Syncona Portfolio St Peter Port, Guernsey $25.7M AUM 13.32% 1-Year Est. Return

TAM

TFG Asset Management Grand Cayman, Cayman Islands $515M AUM 24.47% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HCA

Harbor Capital Advisors Chicago, Illinois $1.23B AUM 30.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Eventide Asset Management's FRLN Position: Q2 2023 in Review

Eventide Asset Management sold out of Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) in Q2 2023, closing a stake of 313,509 shares — an estimated $2.16M sold.

Eventide Asset Management first reported a position in FRLN in Q3 2020 and held it in 11 quarters. The position peaked at $44.3M in Q4 2020. 11 funds tracked by Wall St. Rank hold FRLN as of Q2 2023.

Eventide Asset Management reported no remaining Freeline Therapeutics Holdings plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Eventide Asset Management sold 313,509 Freeline Therapeutics Holdings plc American Depositary Shares shares in Q2 2023, an estimated $2.16M.
Eventide Asset Management first reported a position in Freeline Therapeutics Holdings plc American Depositary Shares in Q3 2020 and held it in 11 quarters.
Eventide Asset Management's Freeline Therapeutics Holdings plc American Depositary Shares position peaked at $44.3M in Q4 2020.
11 funds tracked by Wall St. Rank held Freeline Therapeutics Holdings plc American Depositary Shares as of Q2 2023.

Based on Eventide Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.